Parent-metabolite Physiologically-based Pharmacokinetic/pharmacodynamic (pbpk/pd) Modelling Using Ivabradine, a Cyp3a4 Substrate: Ddi Risk Evaluation in Children.

J Lang; L Vincent; C Marylore; K Ogungbenro; A Galetin

Parent-metabolite Physiologically-based Pharmacokinetic/pharmacodynamic (pbpk/pd) Modelling Using Ivabradine, a Cyp3a4 Substrate: Ddi Risk Evaluation in Children.

J Lang, L Vincent, C Marylore, K Ogungbenro, A Galetin

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S14-S14
Number of pages	1
Journal	Clinical Pharmacology & Therapeutics
Volume	109
Publication status	Published - Mar 2021

Cite this

@article{61ed4f14a0644946a4bb67931a46f252,

title = "Parent-metabolite Physiologically-based Pharmacokinetic/pharmacodynamic (pbpk/pd) Modelling Using Ivabradine, a Cyp3a4 Substrate: Ddi Risk Evaluation in Children.",

author = "J Lang and L Vincent and C Marylore and K Ogungbenro and A Galetin",

year = "2021",

month = mar,

language = "English",

volume = "109",

pages = "S14--S14",

journal = "Clinical Pharmacology & Therapeutics",

issn = "0009-9236",

publisher = "Springer Nature",

}

TY - JOUR

T1 - Parent-metabolite Physiologically-based Pharmacokinetic/pharmacodynamic (pbpk/pd) Modelling Using Ivabradine, a Cyp3a4 Substrate

T2 - Ddi Risk Evaluation in Children.

AU - Lang, J

AU - Vincent, L

AU - Marylore, C

AU - Ogungbenro, K

AU - Galetin, A

PY - 2021/3

Y1 - 2021/3

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:000619875100031&DestLinkType=FullRecord&DestApp=WOS

M3 - Meeting Abstract

SN - 0009-9236

VL - 109

SP - S14-S14

JO - Clinical Pharmacology & Therapeutics

JF - Clinical Pharmacology & Therapeutics

ER -

Parent-metabolite Physiologically-based Pharmacokinetic/pharmacodynamic (pbpk/pd) Modelling Using Ivabradine, a Cyp3a4 Substrate: Ddi Risk Evaluation in Children.

Other files and links

Cite this